Please see below for a list of search results.
The HTA’s high-level aims, objectives and key milestones and deliverables for 2018/19 are set out in this section. This information is supported by our key performance indicators (KPIs) and performance indicators (PIs), which set out how we will measure whether we are achieving those aims.
This business plan sets out our ambitions for 2018/19. The HTA operates a continuous business planning process - we maintain a pipeline of proposed business activities over a three-year period, which allows us to adapt and plan in response to changes in our operating environment.
Our strategy was developed following a fundamental evaluation of the extent to which our current strategic approach protects public and professional confidence in the proper use, and quality and safety, of human tissues, cells and organs.
During 2017, the HTA undertook a fundamental review of its strategy. This exercise gave us considerable reassurance that the public and professionals think we are on the right track with our regulatory approach.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established by the Human Tissue Act 2004.